217 related articles for article (PubMed ID: 18088469)
1. [Expression of HLA-DRB1*15 genotype in children with acquired aplastic anemia and its relation to effect of immunosuppressive therapy].
Huang YL; Huang SL; Huang K; Bao R
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Dec; 15(6):1212-5. PubMed ID: 18088469
[TBL] [Abstract][Full Text] [Related]
2. [Clinical implications of combined measurement bone marrow T cells intracellular IFNgamma and HLA-DRB1*1501 measurement in predicting the response to immunosuppressive therapy for aplastic anemia].
Chen Y; Xu CG; Guo NJ; Huang P; Xiao DJ; Ding BT; Ge LF
Zhonghua Nei Ke Za Zhi; 2007 Oct; 46(10):846-9. PubMed ID: 18218241
[TBL] [Abstract][Full Text] [Related]
3. [Relationship between polymorphism of HLA-A, -B, -DRB1 alleles and susceptibility of children to acquired aplastic anemia].
Lu SY; Xiao LL; Luo M; Zhang BH; Chen C
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Feb; 20(1):120-4. PubMed ID: 22391180
[TBL] [Abstract][Full Text] [Related]
4. [Correlation of HLA-alleles with aplastic anemia].
Liang XL; Qiu LG; Sun LJ; Yu LJ; Han JL; Li Q
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Dec; 15(6):1208-11. PubMed ID: 18088468
[TBL] [Abstract][Full Text] [Related]
5. Response to immunosuppressive therapy and an HLA-DRB1 allele in patients with aplastic anaemia: HLA-DRB1*1501 does not predict response to antithymocyte globulin.
Nakao S; Takami A; Sugimori N; Ueda M; Shiobara S; Matsuda T; Mizoguchi H
Br J Haematol; 1996 Jan; 92(1):155-8. PubMed ID: 8562389
[TBL] [Abstract][Full Text] [Related]
6. Association of human leukocyte antigen class II alleles with response to immunosuppressive therapy in Korean aplastic anemia patients.
Song EY; Kang HJ; Shin HY; Ahn HS; Kim I; Yoon SS; Park S; Kim BK; Park MH
Hum Immunol; 2010 Jan; 71(1):88-92. PubMed ID: 19819281
[TBL] [Abstract][Full Text] [Related]
7. [Immunosuppressive therapy for 54 children patients with acquired severe aplastic anemia].
Chen C; Fang JP; Huang SL; Zhong FY
Zhonghua Er Ke Za Zhi; 2006 Nov; 44(11):841-4. PubMed ID: 17274875
[TBL] [Abstract][Full Text] [Related]
8. Roles of DRB1 *1501 and DRB1 *1502 in the pathogenesis of aplastic anemia.
Sugimori C; Yamazaki H; Feng X; Mochizuki K; Kondo Y; Takami A; Chuhjo T; Kimura A; Teramura M; Mizoguchi H; Omine M; Nakao S
Exp Hematol; 2007 Jan; 35(1):13-20. PubMed ID: 17198869
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of HLA DR2 in acquired aplastic anemia and its impact on response to immunosuppressive therapy.
Usman M; Adil SN; Moatter T; Bilwani F; Arian S; Khurshid M
J Pak Med Assoc; 2004 May; 54(5):251-4. PubMed ID: 15270183
[TBL] [Abstract][Full Text] [Related]
10. Correlations between HLA-A, HLA-B and HLA-DRB1 allele polymorphisms and childhood susceptibility to acquired aplastic anemia.
Chen C; Lu S; Luo M; Zhang B; Xiao L
Acta Haematol; 2012; 128(1):23-7. PubMed ID: 22572536
[TBL] [Abstract][Full Text] [Related]
11. First-line immunosuppressive treatment in children with aplastic anemia: rabbit antithymocyte globulin.
Pawelec K; Salamonowicz M; Panasiuk A; Demkow U; Kowalczyk J; Balwierz W; Zaleska-Czepko E; Chybicka A; Szmyd K; Szczepanski T; Bubala H; Wysocki M; Kurylak A; Wachowiak J; Szpecht D; Młynarski W; Bulas M; Krawczuk-Rybak M; Leszczynska E; Urasinski T; Peregud-Pogorzelski J; Balcerska A; Kaczorowska-Hac B; Matysiak M
Adv Exp Med Biol; 2015; 836():55-62. PubMed ID: 25310948
[TBL] [Abstract][Full Text] [Related]
12. [Transplantation of the bone marrow from a HLA-compatible unrelated donor after immunoablative conditioning in children with acquired aplastic anemia unresponsive to combined immunosuppressive therapy: preliminary results].
Novichkova GA; Maschan MA; Shipitsyna IP; Skvortsova IuV; Persiantseva MI; Lebedeva LL; Bobrynina VO; Baĭdil'dina DD; Goronkova OV; Solopova GG; Khachatrian LA; Petrova UN; Suntsova EV; Kalinina II; Sinitsyna VV; Skorobogatova EV; Balashov DN; Dyshlevaia ZM; Shelikhova LN; Kurnikova EE; Trakhtman PE; Maschan AA
Ter Arkh; 2010; 82(7):41-7. PubMed ID: 20853608
[TBL] [Abstract][Full Text] [Related]
13. [Studies on the predictors of response to immunosuppressive therapy in severe aplastic anemia patients].
Mu XY; Chang H; Liu T; Gong YP; Niu T; Qin H; Ma HB; Meng WT
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Sep; 40(5):897-900. PubMed ID: 19950609
[TBL] [Abstract][Full Text] [Related]
14. Relapse of aplastic anemia in children after immunosuppressive therapy: a report from the Japan Childhood Aplastic Anemia Study Group.
Kamio T; Ito E; Ohara A; Kosaka Y; Tsuchida M; Yagasaki H; Mugishima H; Yabe H; Morimoto A; Ohga S; Muramatsu H; Hama A; Kaneko T; Nagasawa M; Kikuta A; Osugi Y; Bessho F; Nakahata T; Tsukimoto I; Kojima S;
Haematologica; 2011 Jun; 96(6):814-9. PubMed ID: 21422115
[TBL] [Abstract][Full Text] [Related]
15. [The use of allogeneic bone marrow transplantation and immunosuppressive therapy in the treatment of patients with acquired aplastic anemia].
Ganapiev AA; Golubovskaia IK; Zalialov IuR; Estrina MA; Afanas'ev BV
Ter Arkh; 2010; 82(7):48-52. PubMed ID: 20853609
[TBL] [Abstract][Full Text] [Related]
16. [Correlation of HLA-DRB1 gene polymorphism and aplastic anemia in Xinjiang Han people].
Wang F; Hu A; Yang Y; Xie P; Wang X; Qu J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Feb; 30(2):188-90. PubMed ID: 24491062
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppressive therapy in patients with aplastic anemia: a single-center retrospective study.
Jalaeikhoo H; Khajeh-Mehrizi A
PLoS One; 2015; 10(5):e0126925. PubMed ID: 25970182
[TBL] [Abstract][Full Text] [Related]
18. Association of Human Leukocyte Antigen DRB1*15 and DRB1*15:01 Polymorphisms with Response to Immunosuppressive Therapy in Patients with Aplastic Anemia: A Meta-Analysis.
Liu S; Li Q; Zhang Y; Li Q; Ye B; Wu D; Wu L; Lu H; Ji C
PLoS One; 2016; 11(9):e0162382. PubMed ID: 27611583
[TBL] [Abstract][Full Text] [Related]
19. HLA-DRB1*15 and pediatric aplastic anemia.
Oguz FS; Yalman N; Diler AS; Oguz R; Anak S; Dorak MT
Haematologica; 2002 Jul; 87(7):772-4. PubMed ID: 12091130
[TBL] [Abstract][Full Text] [Related]
20. Relapse and clonal disease in children with aplastic anemia (AA) after immunosuppressive therapy (IST): the SAA 94 experience. German/Austrian Pediatric Aplastic Anemia Working Group.
Führer M; Burdach S; Ebell W; Gadner H; Haas R; Harbott J; Janka-Schaub G; Klingebiel T; Kremens B; Niemeyer C; Rampf U; Reiter A; Ritter J; Schulz A; Walther U; Zeidler C; Bender-Götze C
Klin Padiatr; 1998; 210(4):173-9. PubMed ID: 9743949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
